ZSAN Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 saus. 1970 @ 03:00):

Stats
Dzisiejszy wolumen	1.16M
Średni wolumen	5.36M
Kapitalizacja rynkowa	0.00
EPS	$-1.760 ( 2022-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.936
ATR14	$0.221 (39.63%)

Insider Trading

Date	Person	Action	Amount	type
2022-06-06	Matthews Christine	Sell	82	Common Stock
2022-06-06	Lo Steven	Sell	442	Common Stock
2022-03-31	Matthews Christine	Sell	8 116	Common Stock
2022-03-31	Kellerman Donald J	Sell	4 006	Common Stock
2022-03-31	Lo Steven	Sell	23 633	Common Stock

INSIDER POWER
-100.00
Last 98 transactions
Buy: 6 809 170 \| Sell: 191 091

Wolumen Korelacja

Długi: -0.45 (neutral)

Krótki: 0.20 (neutral)

Signal:(26.225) Neutral

Zosano Pharma Corp Korelacja

10 Najbardziej pozytywne korelacje
ARQQ	0.958
FATE	0.945
FNCH	0.941
NKTX	0.941
IMCC	0.941
CFBK	0.94
BNOX	0.939
CFRX	0.938
CELU	0.935
RPID	0.934

10 Najbardziej negatywne korelacje
DVCR	-0.974
OPNT	-0.957
LMNX	-0.951
EWEB	-0.951
AVEO	-0.947
STAY	-0.946
HZNP	-0.943
LUNA	-0.943
NWFL	-0.941
BKCH	-0.939

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zosano Pharma Corp Korelacja - Waluta/Towar

0.35
( neutral )

0.68
( moderate )

0.30
( neutral )

0.25
( neutral )

-0.49
( neutral )

-0.68
( moderate negative )

Zosano Pharma Corp Finanse

Annual	2021
Przychody:	$785 000
Zysk brutto:	$-11 000.00 (-1.40 %)
EPS:	$-0.270

FY	2021
Przychody:	$785 000
Zysk brutto:	$-11 000.00 (-1.40 %)
EPS:	$-0.270

FY	2020
Przychody:	$224 000
Zysk brutto:	$53 000.00 (23.66 %)
EPS:	$-0.490

FY	2019
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-2.29

Financial Reports:

No articles found.

Zosano Pharma Corp

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.